AKT1 and neoplasm: These fragments then bind to the epidermal growth factor receptor (EGFR), activating its downstream Raf/ERK/AKT signaling pathway, inducing F-actin cytoskeleton reorganization, and enhancing tumor cell migration and VM formation ability (Li et al., 2017).